Skip to main content
. 2020 Jun 13;38(9):943–947. doi: 10.1016/j.tibtech.2020.06.004

Figure 2.

Figure 2

Number of Reported Cases per Month and Key Events in the Development of a Novel Vaccine for Global Epidemics and Pandemics over the Last Two Decades.

See Table S1 in the supplemental information online for key events. Data sources: severe acute respiratory syndrome (SARS): World Health Organization (WHO)i; H1N1: WHOii, FluNet/WHO Global Influenza Surveillance and Response System (GISRS)iii (H1N1 data comes from surveillance of global circulation of influenza viruses; number of specimens positive for H1N1 reported to GISRS); Middle East respiratory syndrome (MERS): European Centre for Disease Prevention and Control (ECDC)iv; Ebola: Centers for Disease Control and Prevention (CDC)v; Zika: Pan American Health Organization (PAHO)/WHOvi; COVID19: Johns Hopkins Universityvii (COVID-19 cases for month 4 are from 1 April 2020 to 27 April 2020).

See Table S1 in the supplemental information online for key events. Data sources: severe acute respiratory syndrome (SARS): World Health Organization (WHO)i; H1N1: WHOii, FluNet/WHO Global Influenza Surveillance and Response System (GISRS)iii (H1N1 data comes from surveillance of global circulation of influenza viruses; number of specimens positive for H1N1 reported to GISRS); Middle East respiratory syndrome (MERS): European Centre for Disease Prevention and Control (ECDC)iv; Ebola: Centers for Disease Control and Prevention (CDC)v; Zika: Pan American Health Organization (PAHO)/WHOvi; COVID19: Johns Hopkins Universityvii (COVID-19 cases for month 4 are from 1 April 2020 to 27 April 2020).